Página 1 dos resultados de 4 itens digitais encontrados em 0.007 segundos

‣ Alianças e a sua contribuição no desenvolvimento da capacidade de absorção e no desempenho inovador das empresas dedicadas à biotecnologia; Alliances and its contribution to the development of absorptive capacity and innovation performance of dedicated biotechnology firms

Vicentin, Flavia Oliveira do Prado
Fonte: Biblioteca Digitais de Teses e Dissertações da USP Publicador: Biblioteca Digitais de Teses e Dissertações da USP
Tipo: Tese de Doutorado Formato: application/pdf
Publicado em 27/03/2015 Português
Relevância na Pesquisa
99.94538%
Os mercados cada vez mais competitivos fazem com que as empresas busquem novas formas organizacionais e desenvolvam "capacidades dinâmicas" a fim de sobreviver no mundo globalizado. Nesse contexto, a inovação se tornou tema central para a competitividade. As fontes de inovação estão cada vez mais diversificadas e dispersas geograficamente, as empresas utilizam fontes internas e externas para o desenvolvimento de soluções inovadoras e modelos de negócios diferenciados. Estudos afirmam, que durante todos os anos, são produzidos milhares de artigos científicos que envolvem a biotecnologia, mostrando que é um dos campos mais promissores do mundo, com implicações importantes para economia global. A biotecnologia é caracterizada por ser baseada na ciência, ser multidisciplinar e o seu desenvolvimento é realizado por meio da interface com diversos atores, sendo altamente dependente do seu ambiente institucional. Assim, dado o contexto da biotecnologia, as lentes da teoria das capacidades dinâmicas são úteis para verificar a construção do conhecimento que conduz ao desenvolvimento de novos produtos, já que as empresas não podem depender somente do desenvolvimento do conhecimento interno, elas devem absorver conhecimentos relevantes de fontes externas. No setor de biotecnologia...

‣ A brief overview of the evolution and main features of the biotechnology industry

Fontes, M.; Videira, P.
Fonte: Instituto Universitário de Lisboa Publicador: Instituto Universitário de Lisboa
Tipo: Trabalho em Andamento
Publicado em 26/04/2013 Português
Relevância na Pesquisa
59.26018%
This paper offers an overview of the origin, evolution and main features of the biotechnology industry, putting particular emphasis on the behaviour of one key actor – the dedicated biotechnology firm. It starts with a brief historical background detailing the origin and dynamics of the industry, which is followed by a more detailed examination of the firms’ strategies, business models and networking behaviour. It concludes with a discussion on the constraints and opportunities faced by firms operating outside the main centres of knowledge production and business in biotechnology, as is the case of dedicated biotechnology firms located in Portugal.

‣ Technological learning in microalgae production systems: revisiting the experience curve and the learning mechanisms

Álvarez, Victória del Pino
Fonte: Universidade do Algarve Publicador: Universidade do Algarve
Tipo: Dissertação de Mestrado
Publicado em //2010 Português
Relevância na Pesquisa
18.13769%
Dissertação de mest., Economia da Inovação e do Empreendedorismo, Faculdade de Economia, Univ. do Algarve, 2010; Facing the world scenario, businesses are striving for efficiency and profitability. The processes of innovation, learning, and experience accumulation are, indeed, thought to be crucial for sustaining competitiveness of businesses. The experience curve concept integrates those processes, as it is based on the premise that the more often a task is performed, the lower will be the cost of doing it. Although extensive research has shown that cumulative experience leads to performance improvement, across numerous sectors, our work fills part of the existing knowledge gap by focusing on experience curve and learning aspects of the modern biotechnology of Microalgae Production Systems (MPS). Microalgae are one of the most exciting future-oriented business areas of modern biotechnologies, which have turned into an important global industry, with a diversified field of applications. The particularities of learning and experience accumulation processes were introduced in our work. Our study also addressed some of the applications and misapplications of the experience curve concept. We also reported on some of the perspectives and advances of the MPS...

‣ World Antibody-Drug Conjugate Summit, October 15–16, 2013, San Francisco, CA

Klinguer-Hamour, Christine; Strop, Pavel; Shah, Dhaval K; Ducry, Laurent; Xu, April; Beck, Alain
Fonte: Landes Bioscience Publicador: Landes Bioscience
Tipo: Artigo de Revista Científica
Português
Relevância na Pesquisa
27.783293%
The World Antibody-Drug Conjugate (WADC) Summits organized by Hanson Wade are currently the largest meetings fully dedicated to ADCs. The first global ADC Summit was organized in Boston in October 2010. Since 2011, two WADC are held every year in Frankfurt and San Francisco, respectively. The 2013 WADC San Francisco event was structured around plenary sessions with keynote speakers from AbbVie, Agensys, ImmunoGen, Immunomedics, Genentech, Pfizer and Seattle Genetics. Parallel tracks were also organized addressing ADC discovery, development and optimization of chemistry, manufacturing and control (CMC) issues. Discovery and process scientists, regulatory experts (US Food and Drug Administration), academics and clinicians were present, including representatives from biotechnology firms (Concortis, CytomX Therapeutics, Glykos, Evonik, Igenica, Innate Pharma, Mersana Therapeutics, Polytherics, Quanta Biodesign, Redwood Bioscience, Sutro Biopharma, SynAffix), pharmaceutical companies (Amgen, Genmab, Johnson and Johnson, MedImmune, Novartis, Progenics, Takeda) and contract research or manufacturing organizations (Baxter, Bayer, BSP Pharmaceuticals, Fujifilm/Diosynth, Lonza, Pierre Fabre Contract Manufacturing, Piramal, SAFC, SafeBridge).